Versatope is an immuno-therapeutic company that harnesses a customized biotechnology platform to delivery immunity. State of the art synthetic biology and bioinformatics are used to customize exosome-like vesicles made from probiotics. These vesicles display targets in a 3D context that activates potent immunity. Our lead vaccine candidate addresses the need for improved, effective universal influenza vaccines to prevent influenza, and pandemic preparedness for emerging infectious diseases.